sickle cell anemia therapeutics (OSI)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesickle cell anemia therapeutics (OSI)
Drug Alias Namebeta-thalassemia therapeutics (OSI Pharmaceuticals)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOsi Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOsi Pharmaceuticals Inc
Active IndicationsN/A
Inactive Indicationsbeta-ThalassemiaAnemia, Sickle Cell

Other Information

ATC CodeN/A
Related LinksN/A